Monoclonal antibodies directed against a novel pathogenic west African human immunodeficiency virus type 2 (HIV-2) group F isolate
US-9650435-B2 · May 16, 2017 · US
This patent family groups 1 related publication across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 42170721 |
| Family type | — |
| Earliest priority | Nov 14, 2008 |
| First filing country | US |
| Member publications | 1 |
| Countries | US |
| Representative publication | US9650435B2 — Monoclonal antibodies directed against a novel pathogenic west African human immunodeficiency virus type 2 (HIV-2) group F isolate |
Best representative member for this family based on priority and filing country.
US9650435B2 — Monoclonal antibodies directed against a novel pathogenic west African human immunodeficiency virus type 2 (HIV-2) group F isolate (published May 16, 2017)
Related publications in this family.